Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$42.1K
16 trades · 2 insiders
Net · 90d
$-42.1K
Insiders on file
24
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer | 47 | $0 | $112.5K | 2026-09-10 |
| Ali Faraz | Chief Executive Officer, Director | 43 | $0 | $159.4K | 2026-09-10 |
| Hyllengren Eric J | Chief Financial Officer | 1 | $0 | $0 | 2026-07-13 |
| Burroughs Amy L. | Director | 5 | $0 | $0 | 2026-05-28 |
| Srivastava Deepak | Director | 6 | $600.0K | $0 | 2026-05-28 |
| Stehman-Breen Catherine | Director | 5 | $0 | $0 | 2026-05-28 |
| Lee June | Director | 6 | $0 | $0 | 2026-05-28 |
| Parschauer Karah Herdman | Director | 6 | $0 | $0 | 2026-05-28 |
| Walsh Jeffrey T. | Director | 5 | $0 | $0 | 2026-05-28 |
| Williams R Sanders | Director | 5 | $0 | $0 | 2026-05-28 |
| Higa Tomohiro | SVP, Finance | 14 | $0 | $10.9K | 2026-05-18 |
| TCG Opportunity III GP, LLC | 10% Owner | 4 | $0 | $2.37M | 2026-02-25 |
| COLUMN GROUP III-A, LP | 10% Owner | 10 | $13.90M | $3.54M | 2026-02-23 |
| GOEDDEL DAVID V | Director, 10% Owner | 22 | $64.56M | $0 | 2025-05-29 |
| COLUMN GROUP III, LP | 10% Owner | 13 | $50.02M | $0 | 2025-03-05 |
| Saito Chihiro | SVP, Accounting and Fin. Ops. | 5 | $0 | $11.6K | 2024-11-18 |
| Hoey Timothy | Chief Scientific Officer | 13 | $0 | $145.4K | 2024-03-05 |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | 8 | $0 | $47.4K | 2024-02-23 |
| CHEN JIN-LONG | Director | 2 | $0 | $0 | 2023-06-09 |
| COLUMN GROUP III GP, LP | 10% Owner | 3 | $639.4K | $0 | 2023-01-19 |
| Casdin Capital, LLC | Director | 2 | $10.00M | $0 | 2022-11-17 |
| Casdin Eli | Director, 10% Owner | 7 | $12.75M | $0 | 2022-06-10 |
| Kang JeenJoo | Director | 2 | $0 | $0 | 2021-08-03 |
| Casdin Private Growth Equity Fund, L.P. | 10% Owner | 6 | $12.75M | $0 | 2021-08-03 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2026-09-10 | 2026-09-11 | 293,000 | — | $0 | 293,000 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award deriv | 2026-09-10 | 2026-09-11 | 732,500 | — | $0 | 732,500 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award | 2026-09-10 | 2026-09-11 | 49,000 | — | $0 | 263,073 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award | 2026-09-10 | 2026-09-11 | 122,000 | — | $0 | 539,782 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2026-09-10 | 2026-09-11 | 293,000 | — | $0 | 293,000 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award | 2026-09-10 | 2026-09-11 | 49,000 | — | $0 | 263,073 | SEC↗ |
| Ali Faraz | Chief Executive Officer, Dir | A Award deriv | 2026-09-10 | 2026-09-11 | 732,500 | — | $0 | 732,500 | SEC↗ |
| Ali Faraz | Chief Executive Officer, Dir | A Award | 2026-09-10 | 2026-09-11 | 122,000 | — | $0 | 539,782 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-08-17 | 2026-08-17 | 1,637 | $0.71 | $1.2K | 218,223 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-08-17 | 2026-08-17 | 2,279 | $0.71 | $1.6K | 214,073 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-08-17 | 2026-08-17 | 1,871 | $0.71 | $1.3K | 216,352 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-08-17 | 2026-08-17 | 1,637 | $0.71 | $1.2K | 219,860 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2026-08-17 | 2026-08-17 | 3,969 | $0.71 | $2.8K | 430,208 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2026-08-17 | 2026-08-17 | 5,837 | $0.71 | $4.1K | 434,177 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2026-08-17 | 2026-08-17 | 7,406 | $0.71 | $5.3K | 417,782 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2026-08-17 | 2026-08-17 | 5,020 | $0.71 | $3.6K | 425,188 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-08-17 | 2026-08-17 | 2,279 | $0.71 | $1.6K | 214,073 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-08-17 | 2026-08-17 | 1,871 | $0.71 | $1.3K | 216,352 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-08-17 | 2026-08-17 | 1,637 | $0.71 | $1.2K | 218,223 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-08-17 | 2026-08-17 | 1,637 | $0.71 | $1.2K | 219,860 | SEC↗ |
| Ali Faraz | Chief Executive Officer, Dir | S Sale | 2026-08-17 | 2026-08-17 | 7,406 | $0.71 | $5.3K | 417,782 | SEC↗ |
| Ali Faraz | Chief Executive Officer, Dir | S Sale | 2026-08-17 | 2026-08-17 | 5,020 | $0.71 | $3.6K | 425,188 | SEC↗ |
| Ali Faraz | Chief Executive Officer, Dir | S Sale | 2026-08-17 | 2026-08-17 | 3,969 | $0.71 | $2.8K | 430,208 | SEC↗ |
| Ali Faraz | Chief Executive Officer, Dir | S Sale | 2026-08-17 | 2026-08-17 | 5,837 | $0.71 | $4.1K | 434,177 | SEC↗ |
| Hyllengren Eric J | Chief Financial Officer | A Award deriv | 2026-07-13 | 2026-07-14 | 1,650,000 | — | $0 | 1,650,000 | SEC↗ |
| Burroughs Amy L. | Director | A Award deriv | 2026-05-28 | 2026-05-29 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Lee June | Director | A Award deriv | 2026-05-28 | 2026-05-29 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Parschauer Karah Herdman | Director | A Award deriv | 2026-05-28 | 2026-05-29 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Srivastava Deepak | Director | A Award deriv | 2026-05-28 | 2026-05-29 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Stehman-Breen Catherine | Director | A Award deriv | 2026-05-28 | 2026-05-29 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Walsh Jeffrey T. | Director | A Award deriv | 2026-05-28 | 2026-05-29 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Williams R Sanders | Director | A Award deriv | 2026-05-28 | 2026-05-29 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2026-05-18 | 2026-05-19 | 1,485 | $0.79 | $1.2K | 118,267 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-05-18 | 2026-05-19 | 3,121 | $0.79 | $2.5K | 215,497 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2026-05-18 | 2026-05-19 | 3,390 | $0.79 | $2.7K | 440,014 | SEC↗ |
| TCG Opportunity III GP, LLC | 10% Owner | S Sale | 2026-02-25 | 2026-02-26 | 1,862,545 | $0.56 | $1.04M | 0 | SEC↗ |
| TCG Opportunity III GP, LLC | 10% Owner | S Sale | 2026-02-25 | 2026-02-26 | 1,649,281 | $0.56 | $923.6K | 0 | SEC↗ |
| TCG Opportunity III GP, LLC | 10% Owner | S Sale | 2026-02-24 | 2026-02-26 | 309,228 | $0.62 | $191.7K | 1,649,281 | SEC↗ |
| TCG Opportunity III GP, LLC | 10% Owner | S Sale | 2026-02-24 | 2026-02-26 | 349,212 | $0.62 | $216.5K | 1,862,545 | SEC↗ |
| COLUMN GROUP III-A, LP | 10% Owner | S Sale | 2026-02-23 | 2026-02-24 | 143,709 | $0.60 | $86.2K | 1,958,509 | SEC↗ |
| COLUMN GROUP III-A, LP | 10% Owner | S Sale | 2026-02-23 | 2026-02-24 | 162,291 | $0.60 | $97.4K | 2,211,757 | SEC↗ |
| COLUMN GROUP III-A, LP | 10% Owner | S Sale | 2026-02-20 | 2026-02-24 | 245,965 | $0.61 | $150.0K | 2,102,218 | SEC↗ |
| COLUMN GROUP III-A, LP | 10% Owner | S Sale | 2026-02-20 | 2026-02-24 | 277,769 | $0.61 | $169.4K | 2,374,048 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-02-17 | 2026-02-17 | 1,642 | $0.64 | $1.1K | 222,136 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-02-17 | 2026-02-17 | 1,876 | $0.64 | $1.2K | 218,618 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2026-02-17 | 2026-02-17 | 1,642 | $0.64 | $1.1K | 220,494 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2026-02-17 | 2026-02-17 | 3,979 | $0.64 | $2.5K | 448,436 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2026-02-17 | 2026-02-17 | 5,851 | $0.64 | $3.7K | 452,415 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2026-02-17 | 2026-02-17 | 5,032 | $0.64 | $3.2K | 443,404 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2026-02-17 | 2026-02-17 | 611 | $0.64 | $391 | 122,610 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2026-02-17 | 2026-02-17 | 2,022 | $0.64 | $1.3K | 119,752 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2026-02-17 | 2026-02-17 | 836 | $0.64 | $535 | 121,774 | SEC↗ |
| COLUMN GROUP III-A, LP | 10% Owner | S Sale | 2026-02-11 | 2026-02-12 | 1,905,115 | $0.68 | $1.30M | 2,348,183 | SEC↗ |
| COLUMN GROUP III-A, LP | 10% Owner | S Sale | 2026-02-11 | 2026-02-12 | 2,151,458 | $0.68 | $1.46M | 2,651,817 | SEC↗ |
| COLUMN GROUP III-A, LP | 10% Owner | S Sale | 2026-02-10 | 2026-02-12 | 182,295 | $0.82 | $149.5K | 4,803,275 | SEC↗ |
| COLUMN GROUP III-A, LP | 10% Owner | S Sale | 2026-02-10 | 2026-02-12 | 161,422 | $0.82 | $132.4K | 4,253,298 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award deriv | 2026-02-03 | 2026-02-05 | 952,250 | — | $0 | 952,250 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2026-02-03 | 2026-02-05 | 318,500 | — | $0 | 318,500 | SEC↗ |
| Higa Tomohiro | SVP, Finance | A Award deriv | 2026-02-03 | 2026-02-05 | 175,500 | — | $0 | 175,500 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award | 2026-02-03 | 2026-02-05 | 158,600 | — | $0 | 458,266 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award | 2026-02-03 | 2026-02-05 | 48,750 | — | $0 | 223,778 | SEC↗ |
| Higa Tomohiro | SVP, Finance | A Award | 2026-02-03 | 2026-02-05 | 29,250 | — | $0 | 123,221 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2025-11-17 | 2025-11-17 | 3,126 | $1.33 | $4.2K | 299,666 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2025-11-17 | 2025-11-17 | 2,877 | $1.33 | $3.8K | 169,926 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2025-11-17 | 2025-11-17 | 1,367 | $1.33 | $1.8K | 93,971 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2025-08-18 | 2025-08-18 | 4,920 | $1.25 | $6.2K | 302,792 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2025-08-18 | 2025-08-18 | 3,893 | $1.25 | $4.9K | 307,712 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2025-08-18 | 2025-08-18 | 5,720 | $1.25 | $7.2K | 311,605 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2025-08-18 | 2025-08-18 | 1,837 | $1.25 | $2.3K | 172,803 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2025-08-18 | 2025-08-18 | 1,608 | $1.25 | $2.0K | 174,640 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2025-08-18 | 2025-08-18 | 1,608 | $1.25 | $2.0K | 176,248 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2025-08-18 | 2025-08-18 | 523 | $1.25 | $654 | 97,777 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2025-08-18 | 2025-08-18 | 717 | $1.25 | $896 | 97,060 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2025-08-18 | 2025-08-18 | 1,722 | $1.25 | $2.2K | 95,338 | SEC↗ |
| Parschauer Karah Herdman | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 107,400 | — | $0 | 107,400 | SEC↗ |
| Lee June | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 107,400 | — | $0 | 107,400 | SEC↗ |
| Srivastava Deepak | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 107,400 | — | $0 | 107,400 | SEC↗ |
| Williams R Sanders | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 107,400 | — | $0 | 107,400 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | A Award deriv | 2025-05-29 | 2025-05-30 | 107,400 | — | $0 | 107,400 | SEC↗ |
| Burroughs Amy L. | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 107,400 | — | $0 | 107,400 | SEC↗ |
| Walsh Jeffrey T. | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 107,400 | — | $0 | 107,400 | SEC↗ |
| Stehman-Breen Catherine | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 107,400 | — | $0 | 107,400 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2025-05-16 | 2025-05-16 | 3,189 | $0.44 | $1.4K | 317,325 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2025-05-16 | 2025-05-16 | 2,937 | $0.44 | $1.3K | 171,856 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2025-05-16 | 2025-05-16 | 1,390 | $0.44 | $612 | 98,300 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-10 | 5,794 | $0.54 | $3.1K | 324,461 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-10 | 3,947 | $0.54 | $2.1K | 320,514 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2025-03-10 | 2025-03-10 | 4,073 | $0.54 | $2.2K | 176,391 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2025-03-10 | 2025-03-10 | 1,727 | $0.54 | $933 | 180,464 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2025-03-10 | 2025-03-10 | 1,598 | $0.54 | $863 | 174,793 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2025-03-10 | 2025-03-10 | 620 | $0.54 | $335 | 100,535 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2025-03-10 | 2025-03-10 | 845 | $0.54 | $456 | 99,690 | SEC↗ |
| Higa Tomohiro | SVP, Finance | S Sale | 2025-03-10 | 2025-03-10 | 1,017 | $0.54 | $549 | 101,155 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | P Buy deriv | 2025-03-05 | 2025-03-07 | 17,857,142 | — | $0 | 17,857,142 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | P Buy deriv | 2025-03-05 | 2025-03-07 | 35,714,284 | — | $0 | 35,714,284 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | P Buy deriv | 2025-03-05 | 2025-03-07 | 35,714,284 | — | $0 | 35,714,284 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | P Buy deriv | 2025-03-05 | 2025-03-07 | 17,857,142 | — | $0 | 17,857,142 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | P Buy | 2025-03-05 | 2025-03-07 | 35,714,284 | $0.70 | $25.00M | 49,313,559 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | P Buy | 2025-03-05 | 2025-03-07 | 35,714,284 | $0.70 | $25.00M | 49,313,559 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award deriv | 2025-02-06 | 2025-02-07 | 353,271 | — | $0 | 353,271 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award deriv | 2025-02-06 | 2025-02-07 | 650,000 | — | $0 | 650,000 | SEC↗ |
| Ali Faraz | Chief Executive Officer | D To issuer deriv | 2025-02-06 | 2025-02-07 | 161,214 | — | $0 | 0 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award deriv | 2025-02-06 | 2025-02-07 | 161,214 | — | $0 | 161,214 | SEC↗ |
| Ali Faraz | Chief Executive Officer | D To issuer deriv | 2025-02-06 | 2025-02-07 | 401,390 | — | $0 | 0 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award deriv | 2025-02-06 | 2025-02-07 | 401,390 | — | $0 | 401,390 | SEC↗ |
| Ali Faraz | Chief Executive Officer | D To issuer deriv | 2025-02-06 | 2025-02-07 | 353,271 | — | $0 | 0 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award | 2025-02-06 | 2025-02-07 | 34,424 | — | $0 | 330,255 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award | 2025-02-06 | 2025-02-07 | 107,500 | — | $0 | 295,831 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2025-01-24 | 2025-01-28 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2025-01-24 | 2025-01-28 | 69,982 | — | $0 | 69,982 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | D To issuer deriv | 2025-01-24 | 2025-01-28 | 141,000 | — | $0 | 0 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2025-01-24 | 2025-01-28 | 141,000 | — | $0 | 141,000 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | D To issuer deriv | 2025-01-24 | 2025-01-28 | 205,000 | — | $0 | 0 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2025-01-24 | 2025-01-28 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2025-01-24 | 2025-01-28 | 235,000 | — | $0 | 235,000 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | D To issuer deriv | 2025-01-24 | 2025-01-28 | 69,982 | — | $0 | 0 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | D To issuer deriv | 2025-01-24 | 2025-01-28 | 215,000 | — | $0 | 0 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award | 2025-01-24 | 2025-01-28 | 31,676 | — | $0 | 178,782 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award | 2025-01-24 | 2025-01-28 | 40,000 | — | $0 | 147,106 | SEC↗ |
| Saito Chihiro | SVP, Accounting and Fin. Ops | S Sale | 2024-11-18 | 2024-11-18 | 2,258 | $2.12 | $4.8K | 60,983 | SEC↗ |
| Burroughs Amy L. | Director | A Award deriv | 2024-10-18 | 2024-10-21 | 34,000 | — | $0 | 34,000 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | A Award deriv | 2024-10-18 | 2024-10-21 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Lee June | Director | A Award deriv | 2024-10-18 | 2024-10-21 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Parschauer Karah Herdman | Director | A Award deriv | 2024-10-18 | 2024-10-21 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Srivastava Deepak | Director | A Award deriv | 2024-10-18 | 2024-10-21 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Stehman-Breen Catherine | Director | A Award deriv | 2024-10-18 | 2024-10-21 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Williams R Sanders | Director | A Award deriv | 2024-10-18 | 2024-10-21 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Walsh Jeffrey T. | Director | A Award deriv | 2024-10-18 | 2024-10-21 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2024-08-16 | 2024-08-16 | 3,946 | $2.89 | $11.4K | 188,331 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2024-08-16 | 2024-08-16 | 5,802 | $2.89 | $16.8K | 192,277 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2024-08-16 | 2024-08-16 | 5,803 | $2.89 | $16.8K | 108,731 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2024-08-16 | 2024-08-16 | 1,625 | $2.89 | $4.7K | 107,106 | SEC↗ |
| Saito Chihiro | SVP, Accounting and Fin. Ops | S Sale | 2024-08-16 | 2024-08-19 | 807 | $2.89 | $2.3K | 63,241 | SEC↗ |
| Saito Chihiro | SVP, Accounting and Fin. Ops | S Sale | 2024-08-16 | 2024-08-19 | 654 | $2.89 | $1.9K | 64,048 | SEC↗ |
| Saito Chihiro | SVP, Accounting and Fin. Ops | S Sale | 2024-08-16 | 2024-08-19 | 902 | $2.89 | $2.6K | 64,702 | SEC↗ |
| Saito Chihiro | SVP, Accounting and Fin. Ops | A Award | 2024-08-15 | 2024-08-19 | 25,000 | — | $0 | 65,604 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | S Sale | 2024-03-05 | 2024-03-06 | 3,300 | $7.00 | $23.1K | 245,346 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award deriv | 2024-02-23 | 2024-02-27 | 505,000 | — | $0 | 505,000 | SEC↗ |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | A Award deriv | 2024-02-23 | 2024-02-27 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2024-02-23 | 2024-02-27 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | A Award deriv | 2024-02-23 | 2024-02-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award | 2024-02-23 | 2024-02-27 | 85,000 | — | $0 | 198,079 | SEC↗ |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | A Award | 2024-02-23 | 2024-02-27 | 35,000 | — | $0 | 95,755 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award | 2024-02-23 | 2024-02-27 | 35,000 | — | $0 | 108,534 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | A Award | 2024-02-23 | 2024-02-27 | 12,500 | — | $0 | 248,646 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | S Sale | 2024-02-20 | 2024-02-21 | 200 | $6.17 | $1.2K | 236,146 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | S Sale | 2024-02-20 | 2024-02-21 | 6,369 | $5.31 | $33.8K | 236,346 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2024-02-16 | 2024-02-16 | 6,358 | $5.86 | $37.3K | 113,079 | SEC↗ |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | S Sale | 2024-02-16 | 2024-02-16 | 5,201 | $5.86 | $30.5K | 60,755 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2024-02-16 | 2024-02-16 | 6,500 | $5.86 | $38.1K | 73,534 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | S Sale | 2024-02-16 | 2024-02-16 | 4,681 | $5.86 | $27.4K | 242,715 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | P Buy | 2024-02-12 | 2024-02-14 | 2,222,222 | $4.50 | $10.00M | 13,599,275 | SEC↗ |
| COLUMN GROUP III-A, LP | 10% Owner | P Buy | 2024-02-12 | 2024-02-14 | 2,222,222 | $4.50 | $10.00M | 13,599,275 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | S Sale | 2023-08-29 | 2023-08-29 | 7,243 | $4.26 | $30.9K | 247,396 | SEC↗ |
| Ali Faraz | Chief Executive Officer | S Sale | 2023-08-16 | 2023-08-18 | 5,563 | $3.81 | $21.2K | 119,437 | SEC↗ |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | S Sale | 2023-08-16 | 2023-08-18 | 4,452 | $3.81 | $17.0K | 64,542 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | S Sale | 2023-08-16 | 2023-08-18 | 5,563 | $3.81 | $21.2K | 76,437 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | S Sale | 2023-08-16 | 2023-08-18 | 4,007 | $3.81 | $15.3K | 254,639 | SEC↗ |
| Burroughs Amy L. | Director | A Award deriv | 2023-06-09 | 2023-06-12 | 14,766 | — | $0 | 14,766 | SEC↗ |
| CHEN JIN-LONG | Director | A Award deriv | 2023-06-09 | 2023-06-12 | 29,532 | — | $0 | 29,532 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | A Award deriv | 2023-06-09 | 2023-06-12 | 29,532 | — | $0 | 29,532 | SEC↗ |
| Lee June | Director | A Award deriv | 2023-06-09 | 2023-06-12 | 29,532 | — | $0 | 29,532 | SEC↗ |
| Parschauer Karah Herdman | Director | A Award deriv | 2023-06-09 | 2023-06-12 | 29,532 | — | $0 | 29,532 | SEC↗ |
| Srivastava Deepak | Director | A Award deriv | 2023-06-09 | 2023-06-12 | 29,532 | — | $0 | 29,532 | SEC↗ |
| Stehman-Breen Catherine | Director | A Award deriv | 2023-06-09 | 2023-06-12 | 29,532 | — | $0 | 29,532 | SEC↗ |
| Williams R Sanders | Director | A Award deriv | 2023-06-09 | 2023-06-12 | 29,532 | — | $0 | 29,532 | SEC↗ |
| Walsh Jeffrey T. | Director | A Award deriv | 2023-06-09 | 2023-06-12 | 29,532 | — | $0 | 29,532 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | P Buy | 2023-03-10 | 2023-03-14 | 6,779 | $2.60 | $17.6K | 11,377,053 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | P Buy | 2023-03-10 | 2023-03-14 | 6,779 | $2.60 | $17.6K | 11,377,053 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 675,000 | — | $0 | 675,000 | SEC↗ |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award | 2023-02-15 | 2023-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | A Award | 2023-02-15 | 2023-02-17 | 35,000 | — | $0 | 67,000 | SEC↗ |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | A Award | 2023-02-15 | 2023-02-17 | 30,000 | — | $0 | 32,000 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award | 2023-02-15 | 2023-02-17 | 45,000 | — | $0 | 80,000 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award | 2023-02-15 | 2023-02-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | A Award | 2023-02-15 | 2023-02-17 | 30,000 | — | $0 | 258,646 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | A Award | 2023-02-15 | 2023-02-17 | 30,000 | — | $0 | 228,646 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | P Buy | 2023-02-08 | 2023-02-10 | 1,500,000 | $2.60 | $3.90M | 11,370,274 | SEC↗ |
| COLUMN GROUP III-A, LP | 10% Owner | P Buy | 2023-02-08 | 2023-02-10 | 1,500,000 | $2.60 | $3.90M | 11,370,274 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | P Buy | 2023-01-19 | 2023-01-23 | 69,739 | $2.50 | $174.3K | 9,870,274 | SEC↗ |
| COLUMN GROUP III GP, LP | 10% Owner | P Buy | 2023-01-19 | 2023-01-23 | 69,739 | $2.50 | $174.3K | 9,870,274 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | P Buy | 2023-01-18 | 2023-01-19 | 135,688 | $2.52 | $341.9K | 9,800,535 | SEC↗ |
| COLUMN GROUP III GP, LP | 10% Owner | P Buy | 2023-01-18 | 2023-01-19 | 135,688 | $2.52 | $341.9K | 9,800,535 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | P Buy | 2023-01-17 | 2023-01-19 | 49,463 | $2.49 | $123.2K | 9,664,847 | SEC↗ |
| COLUMN GROUP III GP, LP | 10% Owner | P Buy | 2023-01-17 | 2023-01-19 | 49,463 | $2.49 | $123.2K | 9,664,847 | SEC↗ |
| Burroughs Amy L. | Director | A Award deriv | 2022-12-05 | 2022-12-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | P Buy | 2022-11-21 | 2022-11-23 | 9,615,384 | $2.60 | $25.00M | 9,615,384 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | P Buy | 2022-11-21 | 2022-11-23 | 9,615,384 | $2.60 | $25.00M | 9,615,384 | SEC↗ |
| Srivastava Deepak | Director | P Buy | 2022-11-21 | 2022-12-09 | 230,769 | $2.60 | $600.0K | 372,435 | SEC↗ |
| Casdin Capital, LLC | Director | P Buy deriv | 2022-11-17 | 2022-11-25 | 1,354,111 | $2.60 | $3.52M | 1,354,111 | SEC↗ |
| Casdin Capital, LLC | Director | P Buy | 2022-11-17 | 2022-11-25 | 2,492,042 | $2.60 | $6.48M | 6,078,860 | SEC↗ |
| Parschauer Karah Herdman | Director | A Award deriv | 2022-09-08 | 2022-09-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Williams R Sanders | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 39,727 | — | $0 | 39,727 | SEC↗ |
| Casdin Eli | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 39,727 | — | $0 | 39,727 | SEC↗ |
| CHEN JIN-LONG | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 39,727 | — | $0 | 39,727 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | A Award deriv | 2022-06-10 | 2022-06-13 | 39,727 | — | $0 | 39,727 | SEC↗ |
| Lee June | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 39,727 | — | $0 | 39,727 | SEC↗ |
| Srivastava Deepak | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 39,727 | — | $0 | 39,727 | SEC↗ |
| Stehman-Breen Catherine | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 39,727 | — | $0 | 39,727 | SEC↗ |
| Walsh Jeffrey T. | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 39,727 | — | $0 | 39,727 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | S Sale | 2022-04-26 | 2022-04-28 | 1,353 | $10.13 | $13.7K | 198,646 | SEC↗ |
| Hoey Timothy | Chief Scientific Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 168,000 | — | $0 | 168,000 | SEC↗ |
| Tingley Whittemore | Chief Medical Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 141,000 | — | $0 | 141,000 | SEC↗ |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Ali Faraz | Chief Executive Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 401,390 | — | $0 | 401,390 | SEC↗ |
| Parschauer Karah Herdman | Director | A Award deriv | 2021-12-22 | 2021-12-23 | 19,495 | — | $0 | 19,495 | SEC↗ |
| Lee June | Director | A Award deriv | 2021-11-19 | 2021-11-22 | 18,937 | — | $0 | 18,937 | SEC↗ |
| Kang JeenJoo | Director | C Conversion deriv | 2021-08-03 | 2021-08-04 | 12,500 | — | $0 | 0 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 213,306 | — | $0 | 0 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 188,881 | — | $0 | 0 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 533,781 | — | $0 | 0 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 4,209,755 | — | $0 | 0 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 472,659 | — | $0 | 0 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 3,727,742 | — | $0 | 0 | SEC↗ |
| Casdin Eli | Director, 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 2,012,880 | — | $0 | 0 | SEC↗ |
| Casdin Eli | Director, 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 361,969 | — | $0 | 0 | SEC↗ |
| Casdin Eli | Director, 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 361,969 | — | $0 | 0 | SEC↗ |
| Casdin Private Growth Equity F | 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 361,969 | — | $0 | 0 | SEC↗ |
| Casdin Private Growth Equity F | 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 361,969 | — | $0 | 0 | SEC↗ |
| Casdin Private Growth Equity F | 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 2,012,880 | — | $0 | 0 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 533,781 | — | $0 | 0 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 3,727,742 | — | $0 | 0 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 213,306 | — | $0 | 0 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 188,881 | — | $0 | 0 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 472,659 | — | $0 | 0 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | C Conversion deriv | 2021-08-03 | 2021-08-04 | 4,209,755 | — | $0 | 0 | SEC↗ |
| Kang JeenJoo | Director | C Conversion | 2021-08-03 | 2021-08-04 | 12,500 | — | $0 | 25,000 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | C Conversion | 2021-08-03 | 2021-08-04 | 4,389,282 | — | $0 | 4,414,720 | SEC↗ |
| GOEDDEL DAVID V | Director, 10% Owner | C Conversion | 2021-08-03 | 2021-08-04 | 4,956,842 | — | $0 | 4,985,570 | SEC↗ |
| Casdin Eli | Director, 10% Owner | C Conversion | 2021-08-03 | 2021-08-04 | 2,374,849 | — | $0 | 2,374,849 | SEC↗ |
| Casdin Eli | Director, 10% Owner | C Conversion | 2021-08-03 | 2021-08-04 | 361,969 | — | $0 | 361,969 | SEC↗ |
| Casdin Eli | Director, 10% Owner | P Buy | 2021-08-03 | 2021-08-04 | 850,000 | $15.00 | $12.75M | 3,224,849 | SEC↗ |
| Casdin Private Growth Equity F | 10% Owner | C Conversion | 2021-08-03 | 2021-08-04 | 361,969 | — | $0 | 361,969 | SEC↗ |
| Casdin Private Growth Equity F | 10% Owner | P Buy | 2021-08-03 | 2021-08-04 | 850,000 | $15.00 | $12.75M | 3,224,849 | SEC↗ |
| Casdin Private Growth Equity F | 10% Owner | C Conversion | 2021-08-03 | 2021-08-04 | 2,374,849 | — | $0 | 2,374,849 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | C Conversion | 2021-08-03 | 2021-08-04 | 4,956,842 | — | $0 | 4,985,570 | SEC↗ |
| COLUMN GROUP III, LP | 10% Owner | C Conversion | 2021-08-03 | 2021-08-04 | 4,389,282 | — | $0 | 4,414,720 | SEC↗ |